PLSI — Phoenix Life Sciences International Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$0.06m
Annual cashflow statement for Phoenix Life Sciences International, fiscal year end - February 28th, USD millions except per share, conversion factor applied.
C2015 February 28th | 2016 February 29th | 2017 February 28th | 2018 February 28th | 2019 February 28th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -17.4 | -0.788 | -0.255 | -0.077 | -3.12 |
Non-Cash Items | 16 | 0.121 | 0.219 | 0.076 | 3.76 |
Discontinued Operations | |||||
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.253 | 0.439 | 0.016 | — | -1.51 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Payable / Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -1.15 | -0.228 | -0.02 | -0 | -0.86 |
Other Investing Cash Flow Items | -0.258 | 0.009 | 0.014 | 0 | 0 |
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.258 | 0.009 | 0.014 | 0 | 0 |
Financing Cash Flow Items | 0 | 0 | — | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 1.41 | 0.217 | 0 | 0 | 1.06 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.003 | -0.002 | -0.006 | -0 | 0.201 |